Center for Scientific Review; Notice of Meeting, 14476 [E8-5212]
Download as PDF
<![CDATA[
14476
Federal Register / Vol. 73, No. 53 / Tuesday, March 18, 2008 / Notices
Name of Committee: Oncological Sciences
Integrated Review Group Clinical Oncology
Study Section.
Date: May 19–20, 2008.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications
Place: Residence Inn Bethesda, 7335
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Sharon K. Gubanich, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6204,
MSC 7804, Bethesda, MD 20892, (301) 435–
1767, gubanics@csr.nih.gov.
Name of Committee: Biological Chemistry
and Macromolecular Biophysics Integrated
Review Group Macromolecular Structure and
Function E Study Section.
Date: May 27–28, 2008.
Time: 8:30 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: La Jolla Shores Hotel, 8110 Camino
del Oro, La Jolla, CA 92037.
Contact Person: Nitsa Rosenzweig, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 1102,
MSC 7760, Bethesda, MD 20892, (301) 435–
1747, rosenzweign@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: March 10, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E8–5206 Filed 3–17–08; 8:45 am]
National Cancer Institute; Call for
Nominations for the National Cancer
Institute Director’s Consumer Liaison
Group
National Institutes of Health
mstockstill on PROD1PC66 with NOTICES
Center for Scientific Review; Notice of
Meeting
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of a meeting of the
National Institutes of Health Peer
Review Advisory Committee.
The meeting will be open to the
public, with attendance limited to space
available. Individuals who plan to
attend and need special assistance, such
as sign language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
Name of Committee: National Institutes of
Health Peer Review Advisory Committee.
Date: April 30, 2008.
Time: 8:30 a.m. to 5 p.m.
Agenda: Provide technical and scientific
advice to the Director, National Institutes of
Jkt 214001
BILLING CODE 4140–01–M
National Institutes of Health
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
17:39 Mar 17, 2008
Dated: March 10, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E8–5212 Filed 3–17–08; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
BILLING CODE 4140–01–M
VerDate Aug<31>2005
Health (NIH), the Deputy Director for
Extramural Research, NIH and the Director,
Center for Scientific Review (CSR), on
matters relating broadly to review procedures
and policies for the evaluation of scientific
and technical merit of applications for grants
and awards.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Ballroom Level, Bethesda, MD
20814.
Contact Person: Cheryl A. Kitt, PhD, Center
for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3030,
MSC 7776, Bethesda, MD 20892, 301–435–
1112, kittc@csr.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
The National Cancer Institute (NCI),
the Federal Government’s primary
agency for cancer research, is seeking
nominations for up to six (6) new
members of the NCI Director’s
Consumer Liaison Group (DCLG) who
will be appointed in July 2008. The
DCLG is a Federal chartered advisory
committee of the NCI. It consists of 16
consumer advocates who are involved
in cancer advocacy and who reflect the
diversity among those whose lives are
affected by cancer.
The mission of the DCLG is to advise,
assist, consult with, and make
recommendations to the NCI Director,
from the perspective and viewpoint of
cancer consumer advocates on a wide
variety of issues, programs, and research
priorities. The DCLG serves as a channel
for consumer advocates to voice their
views and concerns. Specifically, the
DCLG members:
• Help develop and establish
processes, mechanisms, and criteria for
PO 00000
Frm 00048
Fmt 4703
Sfmt 4703
identifying appropriate consumer
advocates to serve on a variety of
program and policy advisory
committees responsible for advancing
the mission of the NCI.
• Serve as a primary forum for
discussing issues and concerns and
exchanging viewpoints that are
important to the broad development of
the NCI programmatic and research
priorities.
• Establish and maintain strong
collaborations between the NCI and the
cancer advocacy community to reach
common goals.
Eligibility Requirements for Individual
Members: To serve on the DCLG, a
member must meet the following
minimum eligibility requirements:
• Be involved in the cancer
experience as a cancer survivor, a caregiver to someone who has cancer, or a
professional or volunteer who works
with survivors or those affected by
cancer; and
• Represent a constituency with
whom you communicate regularly on
cancer issues and be able to serve as a
conduit for information both to and
from your constituency.
DCLG members must be committed to
participate fully in all activities of the
DCLG, including at least two meetings
per year in the Bethesda, MD area,
conference calls, and working group
activities.
Criteria for Evaluating Individual
Candidates: Nominees who meet the
minimum eligibility requirements will
be further assessed based on the
following criteria:
• Cancer advocacy experience;
• Possession of strong leadership
skills;
• Communication and collaboration
skills;
• Ability to represent/advise on
broad, cross-cutting cancer issues,
including those NCI priorities identified
by the NCI Director;
• Ability to facilitate dialogue
between NCI and the cancer advocacy
community.
Characteristics of the DCLG: In
addition to the criteria for individual
candidates, the following characteristics
of the DCLG as a group are intended to
ensure that it reflects the breadth and
diversity of the consumer advocacy
community:
• Ethnic and cultural diversity;
• A broad mix of cancer sites;
• Representation of the medically
underserved;
• A range of cancer advocacy
organizations (from small, local to
regional and national);
• A diversity of ages and gender;
• Geographic diversity (including
urban/rural areas).
E:\FR\FM\18MRN1.SGM
18MRN1
]]>Agencies
[Federal Register Volume 73, Number 53 (Tuesday, March 18, 2008)]
[Notices]
[Page 14476]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-5212]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Meeting
Pursuant to section 10(a) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of
the National Institutes of Health Peer Review Advisory Committee.
The meeting will be open to the public, with attendance limited to
space available. Individuals who plan to attend and need special
assistance, such as sign language interpretation or other reasonable
accommodations, should notify the Contact Person listed below in
advance of the meeting.
Name of Committee: National Institutes of Health Peer Review
Advisory Committee.
Date: April 30, 2008.
Time: 8:30 a.m. to 5 p.m.
Agenda: Provide technical and scientific advice to the Director,
National Institutes of Health (NIH), the Deputy Director for
Extramural Research, NIH and the Director, Center for Scientific
Review (CSR), on matters relating broadly to review procedures and
policies for the evaluation of scientific and technical merit of
applications for grants and awards.
Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400
Wisconsin Avenue, Ballroom Level, Bethesda, MD 20814.
Contact Person: Cheryl A. Kitt, PhD, Center for Scientific
Review, National Institutes of Health, 6701 Rockledge Drive, Room
3030, MSC 7776, Bethesda, MD 20892, 301-435-1112, kittc@csr.nih.gov.
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
Dated: March 10, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E8-5212 Filed 3-17-08; 8:45 am]
BILLING CODE 4140-01-M
